X4 Pharmaceuticals, Inc (XFOR) income statement
XFORNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$3.00+0.04 (+1.35%)
Close on Nov 20, 2026Market cap $297.44MP/E –Yield –
X4 Pharmaceuticals, Inc financial ratios
See a number that looks wrong?